This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignee: Pimco 2664 Limited. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chapel-en-le-Frith, GB (2015)
- High Peak, GB (2012 - 2017)
Company Filing History:
Years Active: 2012-2017
Title: Matthew John Tozer: Innovating Therapeutic Compounds for Inflammatory Disorders
Introduction
Matthew John Tozer, an accomplished inventor based in High Peak, Great Britain, is known for his significant contributions to the field of therapeutic compounds. With a remarkable portfolio of six patents, Tozer has dedicated his work to developing treatments for a range of inflammatory and autoimmune disorders, demonstrating a commitment to advancing medical science for the benefit of patients worldwide.
Latest Patents
Among his latest innovations are the aryl-phenyl-sulfonamido-cycloalkyl compounds, collectively referred to as 'APSAC compounds.' These novel compounds are designed to provide therapeutic solutions for various inflammatory conditions, including, but not limited to, rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease (COPD), and atherosclerosis. Furthermore, they hold potential in addressing disorders related to bone loss, such as osteoporosis and can be used in cancer treatments, targeting both hematological malignancies and solid tumors. The pharmaceutical compositions incorporating these APSAC compounds promise to transform therapeutic approaches in treating inflammation and immune-mediated disorders, thereby enhancing patient care and quality of life.
Career Highlights
Matthew is currently associated with Pimco 2664 Limited, where he continues to pioneer innovative solutions in therapeutic developments. His expertise and dedication have set a benchmark in the industry, propelling advancements that are essential for effective treatments of complex medical conditions.
Collaborations
Within his professional journey, Matthew has collaborated with other notable experts like Iain Robert Greig and Rose Mary Sheridan. These partnerships highlight the collaborative nature of scientific research, allowing for the sharing of ideas and fostering innovation that can lead to groundbreaking discoveries in medicine.
Conclusion
In summary, Matthew John Tozer exemplifies the spirit of innovation within the realm of therapeutic compounds. His patents, particularly the APSAC compounds, represent a significant stride in treating challenging health issues, underlining his role as a key inventor in the field. His ongoing work at Pimco 2664 Limited, alongside esteemed colleagues, continues to pave the way for future advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile